These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 20827761

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Exploiting information inherent in binding sites of virus-specific antibodies: design of an HCV vaccine candidate cross-reactive with multiple genotypes.
    Grollo L, Torresi J, Drummer H, Zeng W, Williamson N, Jackson DC.
    Antivir Ther; 2006; 11(8):1005-14. PubMed ID: 17302370
    [Abstract] [Full Text] [Related]

  • 6. Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase.
    Jolivet-Reynaud C, Adida A, Michel S, Deléage G, Paranhos-Baccala G, Gonin V, Battail-Poirot N, Lacoux X, Rolland D.
    J Med Virol; 2004 Mar; 72(3):385-95. PubMed ID: 14748062
    [Abstract] [Full Text] [Related]

  • 7. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
    Ke JS, Zhao P, Cao J, Yu JP, Qi ZT.
    Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1.
    Lechner S, Rispeter K, Meisel H, Kraas W, Jung G, Roggendorf M, Zibert A.
    Virology; 1998 Apr 10; 243(2):313-21. PubMed ID: 9568031
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.
    Mancini N, Canducci F, Carletti S, Berardinelli E, Serafini G, Grieco A, Perotti M, Malcangi G, Danieli MG, Varaldo PE, Clementi M, Burioni R.
    J Biol Regul Homeost Agents; 2003 Apr 10; 17(2):183-7. PubMed ID: 14518720
    [Abstract] [Full Text] [Related]

  • 17. Immunogenic properties of chimeric potato virus X particles displaying the hepatitis C virus hypervariable region I peptide R9.
    Uhde-Holzem K, Schlösser V, Viazov S, Fischer R, Commandeur U.
    J Virol Methods; 2010 Jun 10; 166(1-2):12-20. PubMed ID: 20138085
    [Abstract] [Full Text] [Related]

  • 18. Characterization of epitopes for neutralizing monoclonal antibodies to classical swine fever virus E2 and Erns using phage-displayed random peptide library.
    Zhang F, Yu M, Weiland E, Morrissy C, Zhang N, Westbury H, Wang LF.
    Arch Virol; 2006 Jan 10; 151(1):37-54. PubMed ID: 16132176
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
    Hanuka N, Sikuler E, Tovbin D, Neville L, Nussbaum O, Mostoslavsky M, Orgel M, Yaari A, Manor S, Dagan S, Hilzenrat N, Shemer-Avni Y.
    J Med Virol; 2004 Aug 10; 73(4):529-35. PubMed ID: 15221896
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.